Esophageal Cancer Esophageal Cancer, nutritional support, NAC
Conditions
Interventions
Randomization of oral intake of BCAA products during NAC
Sponsors
Kiyoshi Maeda
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Histologically proven squamous cell carcinoma, adenosquamous carcinoma, or basaloid cell carcinoma. (2)Stage II-III (3)Aged 20 years and older. (4)ECOG Performance status 0 or 1. (5)oral intake is possible (6)Major organ function is preserved. (7)Witten informed consent is obtained.
Exclusion criteria
Exclusion criteria: (1)Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy. (2)Active infection requiring systemic therapy. (3)Fever over 38 degrees Celsius (4)Female during pregnancy, within 28 days of postparturition, or during lactation. Male who wants partner's pregnancy. (5)Psychological disorder difficult to participate in this clinical study. (6)Diabetes mellitus uncontrollable with continuous use of insuline or hypoglycemic agents. (7)Severe emphysema, interstitial pneumonia or pulmonary fibrosis based on chest CT. (8)Uncontrolled arterial hypertension. (9)Drug history of opioids, or stroids. (10)History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration. (11) Allergy for milk (or protein from milk) (12) Other reason why principal investigator considered ineligible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of total skeltal muscle mass index during NAC | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change of Weight, total skeltal muscle mass, appendicular muscle mass, and fat free mass index 2) Continuous rate of BCAA intake 3) Evaluation of appetite 4) Calory intake 5) Adverse events during NAC 6) Postoperative complications 7) Hopital stay after operation | — |
Contacts
Public ContactMiki Yuichiro
Osaka Metropolitan University Hospital
Outcome results
None listed